RE:RE:RE:To sum it up There's risk in everything. No human activity is without some risk. My issue was the author failed to point out how detrimental the delay of USA legalization is to MSO's. If safe doesn't pass giving Curaleaf some access to banking and loans it will be diluting soon. Managment basically said it. All of them have a far worse profile then Tilray Brands despite the revenue they currently generate in Cannabis. They pay high taxes, no access to liquid exchanges and they operate illegally in the eyes of their own federal government. For him to be concerned about risk only to recommend MSO's told me everything in needed to read. He also failed to mention out current success with Sweetwater, Breckeridge and montouk. Proven current success for multiple quarters in a row now with steady growth. Nahhh article was a short sham oldweed